Tumor type and substage predict survival in stage I and II ovarian carcinoma: Insights and implications
Authors:
- Martin KöbelMKMartin Köbel
- Steve E. KallogerSKSteve E. Kalloger
- Jennifer L. SantosJSJennifer L. Santos
- David G. HuntsmanDHDavid G. Huntsman
- C. Blake GilksCGC. Blake Gilks
- Kenneth D. SwenertonKSKenneth D. Swenerton
- 1 January 2010
- journal article
- Published by Elsevier in Gynecologic Oncology
- Vol. 116 (1) , 50-56
Abstract
No abstract availableKeywords
This publication has 34 references indexed in Scilit:
- Ovarian Low-grade and High-grade Serous CarcinomaAdvances in Anatomic Pathology, 2009
- Ovarian CancerAnnual Review of Pathology: Mechanisms of Disease, 2009
- New Insights Into the Pathogenesis of Serous Ovarian Cancer and Its Clinical ImpactJournal of Clinical Oncology, 2008
- Prognostic factors for high‐risk early‐stage epithelial ovarian cancerCancer, 2008
- Early detection and treatment of ovarian cancer: shifting from early stage to minimal volume of disease based on a new model of carcinogenesisAmerican Journal of Obstetrics and Gynecology, 2008
- Early Events in the Pathogenesis of Epithelial Ovarian CancerJournal of Clinical Oncology, 2008
- Grading of serous ovarian carcinoma: further evidence of a lack of agreement between conventional grading systemsHistopathology, 2007
- Prognostic importance of degree of differentiation and cyst rupture in stage I invasive epithelial ovarian carcinomaThe Lancet, 2001
- Lymph Node Metastasis in Stage I Epithelial Ovarian CancerGynecologic Oncology, 2000
- Adjuvant Therapy in Stage I and Stage II Epithelial Ovarian CancerNew England Journal of Medicine, 1990